

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.67004237 |
| 2 | locomotory exploration behavior (GO:0035641) | 5.07105574 |
| 3 | vocalization behavior (GO:0071625) | 4.83243838 |
| 4 | response to histamine (GO:0034776) | 4.82176503 |
| 5 | synaptic vesicle maturation (GO:0016188) | 4.78618023 |
| 6 | neuron cell-cell adhesion (GO:0007158) | 4.77784792 |
| 7 | female mating behavior (GO:0060180) | 4.75667168 |
| 8 | regulation of female receptivity (GO:0045924) | 4.70230004 |
| 9 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.56157712 |
| 10 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 4.47405794 |
| 11 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.45198435 |
| 12 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.38407651 |
| 13 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.29837552 |
| 14 | synaptic vesicle exocytosis (GO:0016079) | 4.29775335 |
| 15 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.29199113 |
| 16 | neurotransmitter secretion (GO:0007269) | 4.20981975 |
| 17 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 4.19708351 |
| 18 | neuromuscular process controlling posture (GO:0050884) | 4.15164649 |
| 19 | neuron recognition (GO:0008038) | 4.14568031 |
| 20 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.13820013 |
| 21 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.10836560 |
| 22 | protein localization to synapse (GO:0035418) | 4.09155661 |
| 23 | regulation of glutamate secretion (GO:0014048) | 4.08020578 |
| 24 | gamma-aminobutyric acid transport (GO:0015812) | 4.03307224 |
| 25 | exploration behavior (GO:0035640) | 4.01958576 |
| 26 | transmission of nerve impulse (GO:0019226) | 3.89887626 |
| 27 | axonal fasciculation (GO:0007413) | 3.87762676 |
| 28 | neurotransmitter transport (GO:0006836) | 3.84894273 |
| 29 | layer formation in cerebral cortex (GO:0021819) | 3.83670153 |
| 30 | glutamate receptor signaling pathway (GO:0007215) | 3.83415046 |
| 31 | glutamate secretion (GO:0014047) | 3.81444742 |
| 32 | activation of protein kinase A activity (GO:0034199) | 3.78784806 |
| 33 | regulation of synaptic vesicle transport (GO:1902803) | 3.77563859 |
| 34 | regulation of protein kinase A signaling (GO:0010738) | 3.77454140 |
| 35 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.67410872 |
| 36 | neuronal action potential propagation (GO:0019227) | 3.66147434 |
| 37 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.65783776 |
| 38 | positive regulation of catecholamine secretion (GO:0033605) | 3.61168340 |
| 39 | mating behavior (GO:0007617) | 3.57269421 |
| 40 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.54234720 |
| 41 | regulation of transmission of nerve impulse (GO:0051969) | 3.53461501 |
| 42 | dendritic spine morphogenesis (GO:0060997) | 3.52656875 |
| 43 | cellular potassium ion homeostasis (GO:0030007) | 3.51932829 |
| 44 | negative regulation of amino acid transport (GO:0051956) | 3.50091277 |
| 45 | proline transport (GO:0015824) | 3.50072311 |
| 46 | positive regulation of synapse assembly (GO:0051965) | 3.47792664 |
| 47 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.46136880 |
| 48 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.44649223 |
| 49 | social behavior (GO:0035176) | 3.43695990 |
| 50 | intraspecies interaction between organisms (GO:0051703) | 3.43695990 |
| 51 | long-term memory (GO:0007616) | 3.43410992 |
| 52 | regulation of neurotransmitter levels (GO:0001505) | 3.39257583 |
| 53 | drinking behavior (GO:0042756) | 3.34695123 |
| 54 | prepulse inhibition (GO:0060134) | 3.33831820 |
| 55 | synaptic transmission, glutamatergic (GO:0035249) | 3.33585347 |
| 56 | neuron-neuron synaptic transmission (GO:0007270) | 3.33167818 |
| 57 | positive regulation of amine transport (GO:0051954) | 3.30960455 |
| 58 | neuronal ion channel clustering (GO:0045161) | 3.26866893 |
| 59 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.24013327 |
| 60 | vesicle transport along microtubule (GO:0047496) | 3.21395636 |
| 61 | neurotransmitter catabolic process (GO:0042135) | 3.18698796 |
| 62 | sodium ion export (GO:0071436) | 3.18093008 |
| 63 | regulation of vesicle fusion (GO:0031338) | 3.17688719 |
| 64 | respiratory system process (GO:0003016) | 3.16263168 |
| 65 | regulation of synaptic transmission, GABAergic (GO:0032228) | 3.14611661 |
| 66 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.14489155 |
| 67 | positive regulation of amino acid transport (GO:0051957) | 3.12658664 |
| 68 | grooming behavior (GO:0007625) | 3.12446992 |
| 69 | postsynaptic membrane organization (GO:0001941) | 3.10425956 |
| 70 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 3.09233333 |
| 71 | regulation of beta-amyloid formation (GO:1902003) | 3.09167817 |
| 72 | aggressive behavior (GO:0002118) | 3.06578053 |
| 73 | presynaptic membrane assembly (GO:0097105) | 3.01764726 |
| 74 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 3.01372616 |
| 75 | cerebellar Purkinje cell layer development (GO:0021680) | 2.99922489 |
| 76 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.96842390 |
| 77 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.96600711 |
| 78 | glycine transport (GO:0015816) | 2.95390346 |
| 79 | membrane depolarization during action potential (GO:0086010) | 2.93959668 |
| 80 | neuromuscular process controlling balance (GO:0050885) | 2.93618618 |
| 81 | suckling behavior (GO:0001967) | 2.92943678 |
| 82 | response to auditory stimulus (GO:0010996) | 2.92718470 |
| 83 | multi-organism reproductive behavior (GO:0044705) | 2.92624528 |
| 84 | behavioral defense response (GO:0002209) | 2.92228212 |
| 85 | behavioral fear response (GO:0001662) | 2.92228212 |
| 86 | maternal behavior (GO:0042711) | 2.92189409 |
| 87 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.89856517 |
| 88 | opioid receptor signaling pathway (GO:0038003) | 2.87968628 |
| 89 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.87638254 |
| 90 | regulation of synapse structural plasticity (GO:0051823) | 2.87619612 |
| 91 | presynaptic membrane organization (GO:0097090) | 2.86325749 |
| 92 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.85215566 |
| 93 | synapse assembly (GO:0007416) | 2.84791267 |
| 94 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.83542472 |
| 95 | regulation of postsynaptic membrane potential (GO:0060078) | 2.82792377 |
| 96 | membrane hyperpolarization (GO:0060081) | 2.82274753 |
| 97 | positive regulation of membrane potential (GO:0045838) | 2.81366675 |
| 98 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.80730272 |
| 99 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.80702003 |
| 100 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.80607719 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.46363626 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.19246646 |
| 3 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.07272479 |
| 4 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.06293757 |
| 5 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.93503999 |
| 6 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.75983962 |
| 7 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.61808505 |
| 8 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.56112341 |
| 9 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.55568441 |
| 10 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.54357658 |
| 11 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.52977222 |
| 12 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.51262828 |
| 13 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.51262828 |
| 14 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.50278506 |
| 15 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.48095912 |
| 16 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.47664996 |
| 17 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.46796642 |
| 18 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.43073570 |
| 19 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.38207500 |
| 20 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.20588112 |
| 21 | * CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.17961756 |
| 22 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.16080414 |
| 23 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.12179181 |
| 24 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.11359741 |
| 25 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.11251620 |
| 26 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.11015266 |
| 27 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.02312638 |
| 28 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.90022625 |
| 29 | * CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.89223799 |
| 30 | * IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.88490928 |
| 31 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.82109531 |
| 32 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.79170108 |
| 33 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.66106982 |
| 34 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.62969335 |
| 35 | P300_19829295_ChIP-Seq_ESCs_Human | 1.61974376 |
| 36 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.61215831 |
| 37 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.60761523 |
| 38 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.48733706 |
| 39 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.45590324 |
| 40 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.41260663 |
| 41 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.40705241 |
| 42 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.38403623 |
| 43 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.38321354 |
| 44 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.37687684 |
| 45 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.36985884 |
| 46 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.36209947 |
| 47 | AR_25329375_ChIP-Seq_VCAP_Human | 1.35657324 |
| 48 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.32573597 |
| 49 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.32564763 |
| 50 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.30238396 |
| 51 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.28144614 |
| 52 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.27940453 |
| 53 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.27656671 |
| 54 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.27652654 |
| 55 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.26985152 |
| 56 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.26258991 |
| 57 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.26035919 |
| 58 | * RNF2_27304074_Chip-Seq_NSC_Mouse | 1.25252969 |
| 59 | * ER_23166858_ChIP-Seq_MCF-7_Human | 1.23518927 |
| 60 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.20283730 |
| 61 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.19990842 |
| 62 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.18994347 |
| 63 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.18861506 |
| 64 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.17271376 |
| 65 | FUS_26573619_Chip-Seq_HEK293_Human | 1.16410316 |
| 66 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.16036645 |
| 67 | STAT3_23295773_ChIP-Seq_U87_Human | 1.15311422 |
| 68 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.13141010 |
| 69 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.12968539 |
| 70 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.12939935 |
| 71 | AR_19668381_ChIP-Seq_PC3_Human | 1.10049258 |
| 72 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.08624754 |
| 73 | TCF4_23295773_ChIP-Seq_U87_Human | 1.06452778 |
| 74 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.06249341 |
| 75 | * JUN_21703547_ChIP-Seq_K562_Human | 1.05650279 |
| 76 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.04015195 |
| 77 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.03146285 |
| 78 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.02538608 |
| 79 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.02357097 |
| 80 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.99584801 |
| 81 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.98687572 |
| 82 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.97959694 |
| 83 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.96611518 |
| 84 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.94917559 |
| 85 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.92008676 |
| 86 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.91581883 |
| 87 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.90163313 |
| 88 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.89537324 |
| 89 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.89537324 |
| 90 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.89415693 |
| 91 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.88374322 |
| 92 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.88095967 |
| 93 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.87681570 |
| 94 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.87418136 |
| 95 | TP53_16413492_ChIP-PET_HCT116_Human | 0.87211663 |
| 96 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.86761320 |
| 97 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.85379769 |
| 98 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.85306428 |
| 99 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.85276114 |
| 100 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.83240487 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003880_abnormal_central_pattern | 5.41791633 |
| 2 | MP0004859_abnormal_synaptic_plasticity | 4.71986463 |
| 3 | MP0003122_maternal_imprinting | 3.82244555 |
| 4 | MP0003635_abnormal_synaptic_transmissio | 3.62915350 |
| 5 | MP0001968_abnormal_touch/_nociception | 3.57482704 |
| 6 | MP0005645_abnormal_hypothalamus_physiol | 3.55633453 |
| 7 | MP0009745_abnormal_behavioral_response | 3.36158984 |
| 8 | MP0006276_abnormal_autonomic_nervous | 3.26815606 |
| 9 | MP0009046_muscle_twitch | 3.14887295 |
| 10 | MP0002064_seizures | 3.14362798 |
| 11 | MP0002063_abnormal_learning/memory/cond | 2.84948103 |
| 12 | MP0005423_abnormal_somatic_nervous | 2.84078276 |
| 13 | MP0001440_abnormal_grooming_behavior | 2.80897951 |
| 14 | MP0002572_abnormal_emotion/affect_behav | 2.67771083 |
| 15 | MP0004270_analgesia | 2.54155169 |
| 16 | MP0001501_abnormal_sleep_pattern | 2.46371332 |
| 17 | MP0002736_abnormal_nociception_after | 2.43775227 |
| 18 | MP0002272_abnormal_nervous_system | 2.41680574 |
| 19 | MP0005646_abnormal_pituitary_gland | 2.35440109 |
| 20 | MP0002734_abnormal_mechanical_nocicepti | 2.23300546 |
| 21 | MP0001486_abnormal_startle_reflex | 2.17946290 |
| 22 | MP0003123_paternal_imprinting | 2.07354277 |
| 23 | MP0002067_abnormal_sensory_capabilities | 1.98942531 |
| 24 | MP0004142_abnormal_muscle_tone | 1.95280003 |
| 25 | MP0002733_abnormal_thermal_nociception | 1.95071727 |
| 26 | MP0002735_abnormal_chemical_nociception | 1.93438853 |
| 27 | MP0003329_amyloid_beta_deposits | 1.92658147 |
| 28 | MP0001970_abnormal_pain_threshold | 1.90606068 |
| 29 | MP0002557_abnormal_social/conspecific_i | 1.78391596 |
| 30 | MP0003787_abnormal_imprinting | 1.77358084 |
| 31 | MP0003121_genomic_imprinting | 1.75312298 |
| 32 | MP0004924_abnormal_behavior | 1.72611745 |
| 33 | MP0005386_behavior/neurological_phenoty | 1.72611745 |
| 34 | MP0002822_catalepsy | 1.66600613 |
| 35 | MP0001502_abnormal_circadian_rhythm | 1.64783651 |
| 36 | MP0001529_abnormal_vocalization | 1.62325015 |
| 37 | MP0000751_myopathy | 1.58211391 |
| 38 | MP0001905_abnormal_dopamine_level | 1.55495315 |
| 39 | MP0003690_abnormal_glial_cell | 1.54552085 |
| 40 | MP0003283_abnormal_digestive_organ | 1.50795433 |
| 41 | MP0001984_abnormal_olfaction | 1.47409982 |
| 42 | MP0008569_lethality_at_weaning | 1.42900502 |
| 43 | MP0002909_abnormal_adrenal_gland | 1.42464029 |
| 44 | MP0009780_abnormal_chondrocyte_physiolo | 1.42168824 |
| 45 | MP0002184_abnormal_innervation | 1.39392607 |
| 46 | MP0000778_abnormal_nervous_system | 1.34185016 |
| 47 | MP0004145_abnormal_muscle_electrophysio | 1.29384936 |
| 48 | MP0002066_abnormal_motor_capabilities/c | 1.29351377 |
| 49 | MP0004885_abnormal_endolymph | 1.28014411 |
| 50 | MP0004811_abnormal_neuron_physiology | 1.21282230 |
| 51 | MP0000013_abnormal_adipose_tissue | 1.21186942 |
| 52 | MP0003633_abnormal_nervous_system | 1.20924584 |
| 53 | MP0002882_abnormal_neuron_morphology | 1.16014890 |
| 54 | MP0004858_abnormal_nervous_system | 1.14055352 |
| 55 | MP0008872_abnormal_physiological_respon | 1.12461089 |
| 56 | MP0000955_abnormal_spinal_cord | 1.12192729 |
| 57 | MP0002837_dystrophic_cardiac_calcinosis | 1.06631962 |
| 58 | MP0006072_abnormal_retinal_apoptosis | 1.02904796 |
| 59 | MP0000604_amyloidosis | 1.01201888 |
| 60 | MP0002069_abnormal_eating/drinking_beha | 0.98143736 |
| 61 | MP0003631_nervous_system_phenotype | 0.95344493 |
| 62 | MP0002876_abnormal_thyroid_physiology | 0.94820646 |
| 63 | MP0005551_abnormal_eye_electrophysiolog | 0.93156930 |
| 64 | MP0003634_abnormal_glial_cell | 0.92699933 |
| 65 | MP0005623_abnormal_meninges_morphology | 0.92661841 |
| 66 | MP0000920_abnormal_myelination | 0.91996295 |
| 67 | MP0004742_abnormal_vestibular_system | 0.91007306 |
| 68 | MP0002229_neurodegeneration | 0.90371424 |
| 69 | MP0000631_abnormal_neuroendocrine_gland | 0.89163802 |
| 70 | MP0002152_abnormal_brain_morphology | 0.88365468 |
| 71 | MP0008874_decreased_physiological_sensi | 0.86496293 |
| 72 | MP0000747_muscle_weakness | 0.82972605 |
| 73 | MP0005379_endocrine/exocrine_gland_phen | 0.79935974 |
| 74 | MP0003879_abnormal_hair_cell | 0.79558945 |
| 75 | MP0008961_abnormal_basal_metabolism | 0.79146592 |
| 76 | MP0001177_atelectasis | 0.77655435 |
| 77 | MP0005535_abnormal_body_temperature | 0.73994949 |
| 78 | MP0004215_abnormal_myocardial_fiber | 0.72357678 |
| 79 | MP0004085_abnormal_heartbeat | 0.72164310 |
| 80 | MP0003959_abnormal_lean_body | 0.71090627 |
| 81 | MP0003137_abnormal_impulse_conducting | 0.69231426 |
| 82 | MP0005448_abnormal_energy_balance | 0.69157132 |
| 83 | MP0001188_hyperpigmentation | 0.68990878 |
| 84 | MP0001299_abnormal_eye_distance/ | 0.68675490 |
| 85 | MP0003075_altered_response_to | 0.67924131 |
| 86 | MP0001963_abnormal_hearing_physiology | 0.67469678 |
| 87 | MP0005253_abnormal_eye_physiology | 0.64861696 |
| 88 | MP0000639_abnormal_adrenal_gland | 0.64031505 |
| 89 | MP0003632_abnormal_nervous_system | 0.62915852 |
| 90 | MP0002638_abnormal_pupillary_reflex | 0.61584608 |
| 91 | MP0002752_abnormal_somatic_nervous | 0.61440407 |
| 92 | MP0008877_abnormal_DNA_methylation | 0.60020546 |
| 93 | MP0002090_abnormal_vision | 0.58809689 |
| 94 | MP0001943_abnormal_respiration | 0.56234758 |
| 95 | MP0005499_abnormal_olfactory_system | 0.50906457 |
| 96 | MP0005394_taste/olfaction_phenotype | 0.50906457 |
| 97 | MP0005452_abnormal_adipose_tissue | 0.50234515 |
| 98 | MP0005167_abnormal_blood-brain_barrier | 0.49804621 |
| 99 | MP0000230_abnormal_systemic_arterial | 0.49746690 |
| 100 | MP0010234_abnormal_vibrissa_follicle | 0.49742122 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 6.22491152 |
| 2 | Focal seizures (HP:0007359) | 5.27208074 |
| 3 | Atonic seizures (HP:0010819) | 5.14932532 |
| 4 | Myokymia (HP:0002411) | 4.69231782 |
| 5 | Absence seizures (HP:0002121) | 4.51386683 |
| 6 | Visual hallucinations (HP:0002367) | 4.30359155 |
| 7 | Dialeptic seizures (HP:0011146) | 4.08535536 |
| 8 | Generalized tonic-clonic seizures (HP:0002069) | 4.06019713 |
| 9 | Abnormal eating behavior (HP:0100738) | 4.03859378 |
| 10 | Polyphagia (HP:0002591) | 4.01431315 |
| 11 | Febrile seizures (HP:0002373) | 3.96678957 |
| 12 | Epileptic encephalopathy (HP:0200134) | 3.78621694 |
| 13 | Abnormal ciliary motility (HP:0012262) | 3.76937320 |
| 14 | Progressive cerebellar ataxia (HP:0002073) | 3.73947860 |
| 15 | Supranuclear gaze palsy (HP:0000605) | 3.71596730 |
| 16 | Anxiety (HP:0000739) | 3.39859479 |
| 17 | Neurofibrillary tangles (HP:0002185) | 3.36405277 |
| 18 | Papilledema (HP:0001085) | 3.30509543 |
| 19 | Agitation (HP:0000713) | 3.27765473 |
| 20 | Abnormal respiratory motile cilium physiology (HP:0012261) | 3.18011553 |
| 21 | Truncal ataxia (HP:0002078) | 3.12881710 |
| 22 | Abnormal respiratory motile cilium morphology (HP:0005938) | 3.11654640 |
| 23 | Abnormal respiratory epithelium morphology (HP:0012253) | 3.11654640 |
| 24 | Broad-based gait (HP:0002136) | 3.05803326 |
| 25 | Depression (HP:0000716) | 3.05599702 |
| 26 | Failure to thrive in infancy (HP:0001531) | 2.95776720 |
| 27 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.91758223 |
| 28 | Pheochromocytoma (HP:0002666) | 2.87778758 |
| 29 | Dysmetria (HP:0001310) | 2.86144236 |
| 30 | Mutism (HP:0002300) | 2.83841990 |
| 31 | Dysdiadochokinesis (HP:0002075) | 2.80883105 |
| 32 | Hemiparesis (HP:0001269) | 2.74850206 |
| 33 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.74283937 |
| 34 | Action tremor (HP:0002345) | 2.71431146 |
| 35 | Absent/shortened dynein arms (HP:0200106) | 2.71426859 |
| 36 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.71426859 |
| 37 | Psychosis (HP:0000709) | 2.71195292 |
| 38 | Progressive inability to walk (HP:0002505) | 2.67905600 |
| 39 | Cerebral inclusion bodies (HP:0100314) | 2.66917387 |
| 40 | Poor eye contact (HP:0000817) | 2.66544410 |
| 41 | Postural instability (HP:0002172) | 2.66180133 |
| 42 | Drooling (HP:0002307) | 2.64409670 |
| 43 | Excessive salivation (HP:0003781) | 2.64409670 |
| 44 | Ankle clonus (HP:0011448) | 2.61719683 |
| 45 | Neuroendocrine neoplasm (HP:0100634) | 2.56870595 |
| 46 | Rhinitis (HP:0012384) | 2.52886223 |
| 47 | Impaired social interactions (HP:0000735) | 2.52393771 |
| 48 | Abnormal social behavior (HP:0012433) | 2.52393771 |
| 49 | Hypoventilation (HP:0002791) | 2.49909400 |
| 50 | Abnormal hair whorl (HP:0010721) | 2.36484526 |
| 51 | Hyperthyroidism (HP:0000836) | 2.33897611 |
| 52 | Hyperventilation (HP:0002883) | 2.33696517 |
| 53 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.33141359 |
| 54 | Diplopia (HP:0000651) | 2.30051350 |
| 55 | Abnormality of binocular vision (HP:0011514) | 2.30051350 |
| 56 | Esotropia (HP:0000565) | 2.30039721 |
| 57 | Menstrual irregularities (HP:0000858) | 2.29868469 |
| 58 | Abnormality of the corticospinal tract (HP:0002492) | 2.29085755 |
| 59 | Status epilepticus (HP:0002133) | 2.28011796 |
| 60 | Termporal pattern (HP:0011008) | 2.27375669 |
| 61 | Insidious onset (HP:0003587) | 2.27375669 |
| 62 | Blue irides (HP:0000635) | 2.25490581 |
| 63 | Abnormality of the labia minora (HP:0012880) | 2.25341595 |
| 64 | Spastic gait (HP:0002064) | 2.24776979 |
| 65 | Fetal akinesia sequence (HP:0001989) | 2.24164019 |
| 66 | Scanning speech (HP:0002168) | 2.20218653 |
| 67 | Bradykinesia (HP:0002067) | 2.19545774 |
| 68 | Neuronal loss in central nervous system (HP:0002529) | 2.17559901 |
| 69 | Sleep apnea (HP:0010535) | 2.13681488 |
| 70 | Hemiplegia (HP:0002301) | 2.12648215 |
| 71 | Ventricular fibrillation (HP:0001663) | 2.10954089 |
| 72 | Ankyloglossia (HP:0010296) | 2.09956907 |
| 73 | Urinary urgency (HP:0000012) | 2.06994438 |
| 74 | Narrow nasal bridge (HP:0000446) | 2.06993873 |
| 75 | Oligomenorrhea (HP:0000876) | 2.06470705 |
| 76 | Specific learning disability (HP:0001328) | 2.05356310 |
| 77 | Abnormal EKG (HP:0003115) | 2.04916136 |
| 78 | Poor suck (HP:0002033) | 2.04158945 |
| 79 | Postural tremor (HP:0002174) | 2.03007969 |
| 80 | Diaphragmatic weakness (HP:0009113) | 2.02748586 |
| 81 | Peripheral hypomyelination (HP:0007182) | 2.02090300 |
| 82 | Generalized myoclonic seizures (HP:0002123) | 2.02063625 |
| 83 | Lower limb muscle weakness (HP:0007340) | 2.01436886 |
| 84 | Hypoglycemic seizures (HP:0002173) | 2.00635765 |
| 85 | Amblyopia (HP:0000646) | 1.95747245 |
| 86 | Gait imbalance (HP:0002141) | 1.94888947 |
| 87 | Gaze-evoked nystagmus (HP:0000640) | 1.94518736 |
| 88 | Abnormality of pain sensation (HP:0010832) | 1.93109813 |
| 89 | Impaired pain sensation (HP:0007328) | 1.93109813 |
| 90 | Anosmia (HP:0000458) | 1.92355326 |
| 91 | Intention tremor (HP:0002080) | 1.91601907 |
| 92 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.90525459 |
| 93 | Aplasia of the phalanges of the hand (HP:0009802) | 1.90525459 |
| 94 | Aplasia involving bones of the extremities (HP:0009825) | 1.90525459 |
| 95 | Prolonged QT interval (HP:0001657) | 1.87959404 |
| 96 | Epileptiform EEG discharges (HP:0011182) | 1.86904468 |
| 97 | Genetic anticipation (HP:0003743) | 1.86854361 |
| 98 | EEG with generalized epileptiform discharges (HP:0011198) | 1.86253523 |
| 99 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.82918803 |
| 100 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.82918803 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 5.30595126 |
| 2 | MAP3K9 | 3.80661084 |
| 3 | PNCK | 3.44602882 |
| 4 | MAP3K12 | 3.44297486 |
| 5 | MAP3K4 | 3.13773832 |
| 6 | NTRK2 | 2.91191391 |
| 7 | EPHA4 | 2.70697982 |
| 8 | MARK1 | 2.57794342 |
| 9 | MINK1 | 2.55910357 |
| 10 | MAP2K7 | 2.36361708 |
| 11 | MAP2K4 | 2.33539255 |
| 12 | TNIK | 2.22031815 |
| 13 | NTRK1 | 2.12192494 |
| 14 | ARAF | 1.96045897 |
| 15 | FES | 1.79598708 |
| 16 | KSR2 | 1.76137237 |
| 17 | TNK2 | 1.69208879 |
| 18 | PAK6 | 1.67511518 |
| 19 | MAP3K13 | 1.62187783 |
| 20 | UHMK1 | 1.49902469 |
| 21 | CASK | 1.45493998 |
| 22 | CDK5 | 1.41983423 |
| 23 | PAK3 | 1.34990532 |
| 24 | GRK7 | 1.22817962 |
| 25 | WNK3 | 1.19971262 |
| 26 | MAPK13 | 1.15793158 |
| 27 | CAMK2A | 1.15404752 |
| 28 | PRKCG | 1.14152095 |
| 29 | OXSR1 | 1.13923607 |
| 30 | CAMK1G | 1.11934525 |
| 31 | ADRBK2 | 1.10971600 |
| 32 | CAMKK1 | 1.10649899 |
| 33 | CDK19 | 1.08539566 |
| 34 | PRKCH | 1.08490058 |
| 35 | TYRO3 | 1.07673937 |
| 36 | LATS2 | 1.04269330 |
| 37 | KSR1 | 1.02806344 |
| 38 | STK39 | 1.02741670 |
| 39 | STK38 | 1.00782014 |
| 40 | SIK2 | 1.00558304 |
| 41 | PHKG1 | 0.98227839 |
| 42 | PHKG2 | 0.98227839 |
| 43 | RIPK4 | 0.93348978 |
| 44 | FER | 0.92342583 |
| 45 | MAP3K2 | 0.92150635 |
| 46 | GRK5 | 0.91191291 |
| 47 | DAPK2 | 0.88735477 |
| 48 | CAMK2B | 0.87074137 |
| 49 | CAMK1 | 0.87005529 |
| 50 | CAMKK2 | 0.84732612 |
| 51 | NME1 | 0.82349985 |
| 52 | SGK494 | 0.81696366 |
| 53 | SGK223 | 0.81696366 |
| 54 | CAMK2D | 0.78844532 |
| 55 | STK11 | 0.75276914 |
| 56 | PLK2 | 0.73943331 |
| 57 | AKT3 | 0.73210771 |
| 58 | CDK14 | 0.70699940 |
| 59 | ADRBK1 | 0.68666556 |
| 60 | MAP3K1 | 0.68649385 |
| 61 | CAMK2G | 0.67457709 |
| 62 | LMTK2 | 0.66952586 |
| 63 | RET | 0.63977470 |
| 64 | MOS | 0.61426402 |
| 65 | CDK18 | 0.61140398 |
| 66 | CDK15 | 0.60426733 |
| 67 | SGK1 | 0.60258993 |
| 68 | PRKD3 | 0.59785625 |
| 69 | SCYL2 | 0.58960737 |
| 70 | ALK | 0.57777166 |
| 71 | RAF1 | 0.57217199 |
| 72 | DAPK1 | 0.57066718 |
| 73 | PINK1 | 0.56366150 |
| 74 | PRKCE | 0.55872095 |
| 75 | TSSK6 | 0.55101023 |
| 76 | RPS6KA3 | 0.54822036 |
| 77 | BCR | 0.54788132 |
| 78 | CDC42BPA | 0.53846621 |
| 79 | CSNK1G2 | 0.53601942 |
| 80 | WNK4 | 0.53449423 |
| 81 | MAPK10 | 0.52572297 |
| 82 | WNK1 | 0.52379895 |
| 83 | NEK6 | 0.52216016 |
| 84 | ROCK2 | 0.51141101 |
| 85 | CDK11A | 0.48273285 |
| 86 | MAPKAPK5 | 0.47850312 |
| 87 | PKN1 | 0.46652886 |
| 88 | FYN | 0.46216703 |
| 89 | PDPK1 | 0.45247546 |
| 90 | FGFR2 | 0.44299441 |
| 91 | PRKACA | 0.43326472 |
| 92 | CSNK1E | 0.42451081 |
| 93 | SGK2 | 0.42232895 |
| 94 | PRKG1 | 0.40527231 |
| 95 | PRKCA | 0.39772554 |
| 96 | IRAK2 | 0.39246897 |
| 97 | PDK1 | 0.38504814 |
| 98 | PRKACG | 0.36190546 |
| 99 | PRKCB | 0.36015377 |
| 100 | FGR | 0.35625683 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 4.73983306 |
| 2 | GABAergic synapse_Homo sapiens_hsa04727 | 3.44896351 |
| 3 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.94572127 |
| 4 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.91063161 |
| 5 | Morphine addiction_Homo sapiens_hsa05032 | 2.74805406 |
| 6 | Olfactory transduction_Homo sapiens_hsa04740 | 2.41427682 |
| 7 | Circadian entrainment_Homo sapiens_hsa04713 | 2.40519191 |
| 8 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.39928716 |
| 9 | Long-term potentiation_Homo sapiens_hsa04720 | 2.19328728 |
| 10 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.08933467 |
| 11 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.04729219 |
| 12 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.02470437 |
| 13 | Taste transduction_Homo sapiens_hsa04742 | 2.01059157 |
| 14 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.94086715 |
| 15 | Salivary secretion_Homo sapiens_hsa04970 | 1.91699526 |
| 16 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.88794230 |
| 17 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.87304340 |
| 18 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.84995057 |
| 19 | Renin secretion_Homo sapiens_hsa04924 | 1.79167581 |
| 20 | Cocaine addiction_Homo sapiens_hsa05030 | 1.77627355 |
| 21 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.75215629 |
| 22 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.74629250 |
| 23 | Long-term depression_Homo sapiens_hsa04730 | 1.74435170 |
| 24 | Insulin secretion_Homo sapiens_hsa04911 | 1.71169285 |
| 25 | Parkinsons disease_Homo sapiens_hsa05012 | 1.60680439 |
| 26 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.54423371 |
| 27 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.51223820 |
| 28 | Alzheimers disease_Homo sapiens_hsa05010 | 1.47527347 |
| 29 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.45800475 |
| 30 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.41837581 |
| 31 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.40402386 |
| 32 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.38883502 |
| 33 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.34355555 |
| 34 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.30943953 |
| 35 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.27406884 |
| 36 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.23077123 |
| 37 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.22336014 |
| 38 | Huntingtons disease_Homo sapiens_hsa05016 | 1.19248709 |
| 39 | Gap junction_Homo sapiens_hsa04540 | 1.18714261 |
| 40 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.13561094 |
| 41 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.12482588 |
| 42 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.09010085 |
| 43 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.07216302 |
| 44 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.02190932 |
| 45 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.02151080 |
| 46 | Melanogenesis_Homo sapiens_hsa04916 | 0.98491055 |
| 47 | Axon guidance_Homo sapiens_hsa04360 | 0.88487984 |
| 48 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.86927580 |
| 49 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.83259796 |
| 50 | Prion diseases_Homo sapiens_hsa05020 | 0.83063426 |
| 51 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.81513066 |
| 52 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.80762631 |
| 53 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.79801875 |
| 54 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.76670257 |
| 55 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.76092031 |
| 56 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.75249782 |
| 57 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.72570502 |
| 58 | Bile secretion_Homo sapiens_hsa04976 | 0.72441841 |
| 59 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.71193468 |
| 60 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.70784581 |
| 61 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.70122705 |
| 62 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.67260405 |
| 63 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.65954974 |
| 64 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.64997124 |
| 65 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.64604067 |
| 66 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.63689432 |
| 67 | Glioma_Homo sapiens_hsa05214 | 0.59255172 |
| 68 | Phototransduction_Homo sapiens_hsa04744 | 0.58103345 |
| 69 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.56231436 |
| 70 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.48298055 |
| 71 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.48230972 |
| 72 | Alcoholism_Homo sapiens_hsa05034 | 0.47609667 |
| 73 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.46828481 |
| 74 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.42886983 |
| 75 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.40230440 |
| 76 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.39917618 |
| 77 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.39231771 |
| 78 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.38929489 |
| 79 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.37904522 |
| 80 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.36857354 |
| 81 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.36793259 |
| 82 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.28720629 |
| 83 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.28527631 |
| 84 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.28525175 |
| 85 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.27754897 |
| 86 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.27038039 |
| 87 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.26951324 |
| 88 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.26747286 |
| 89 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.26169775 |
| 90 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.24860515 |
| 91 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.24070358 |
| 92 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.22843593 |
| 93 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.21823903 |
| 94 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.21371007 |
| 95 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.19485810 |
| 96 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.18572777 |
| 97 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.16432564 |
| 98 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.16291285 |
| 99 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.15519303 |
| 100 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.14937081 |

